Compass Therapeutics Files Initial Beneficial Ownership Statement for Chief Medical Officer Cynthia Sirard
Reuters
Jan 06
Compass <a href="https://laohu8.com/S/LENZ">Therapeutics</a> Files Initial Beneficial Ownership Statement for Chief Medical Officer Cynthia Sirard
Compass Therapeutics Inc. has filed an initial statement of beneficial ownership. The filing names Cynthia Sirard, who serves as the company’s Chief Medical Officer, as the beneficial owner. The full filing can be accessed through the link below.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Compass Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001171843-26-000050), on January 05, 2026, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.